ExoDx Active Surveillance (Prostate Cancer)

ExoDx Active Surveillance (Prostate Cancer)

Es posible que algunos contenidos no estén disponibles en español.

Purpose of this Study

We are doing this study to learn more about a medical technology called the ExoDx Prostate test. We want to find out if these test results can help us evaluate the risk of prostate cancer for patients and make better informed clinical decisions.

Who Can Participate?

Eligibility

Men ages 45+ who:
  • Have low-intermediate risk prostate cancer
  • Are on active surveillance
  • Are scheduled for their second (confirmatory) biopsy
For more information, contact the study team at shawna.pochan@duke.edu.

Age Range

45-110

Sex/Genders

Male (cisgender)
Non-binary or gender fluid
Transgender female
Looking for Healthy Participants
No

What is Involved?

Description

If you choose to join this study, we will ask you to provide a urine sample before you have your scheduled biopsy.

Locations

Duke University Hospital

Visit Timing

Weekdays

Compensation

Yes

Spanish Materials Available

No

Study Details

Full Title

Evaluation of ExoDx Prostate in Men with Prostate Cancer in an Active
Surveillance Regimen- A Prospective Trial

Principal Investigator

Judd
Moul

Protocol Number

PRO00111203

NCT ID

NCT05572099

Phase

N/A

Enrollment Status

Open to Enrollment
ClinicalTrials.gov